ELAN Stock Analysis: Buy, Sell, or Hold?
ELAN - Elanco Animal Health Incorporated Common Stock
$24.57
0.94 (3.98%)
▲
5d:
+3.71%
30d:
+9.15%
90d:
+0.53%
BUY
MODERATE Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When ELAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELAN shows positive signals but monitor for confirmation. Market pricing in 1.4% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ELAN shows positive signals but monitor for confirmation. Market pricing in 1.4% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.56
Based on 8.0% avg growth
INTRINSIC VALUE TODAY
$23.32
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELAN is currently trading at $24.57, which is considered extended relative to its 30-day fair value range of $20.98 to $23.95. The stock's valuation (Forward PE: 20.2) is in line with its historical norms (21.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ELAN is in a downtrend. The price is approaching resistance at $24.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: ELAN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.79 (+21.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELAN is in a downtrend. The price is approaching resistance at $24.63. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: ELAN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.79 (+21.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.98 -
$23.95
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 21.2% below Wall St target ($29.79)
Trading Range Analysis
30-Day Trading Range
$20.98 -
$23.95
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$19.85
Resistance Level
$24.63
Current Trend
Downtrend
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
20.25
Wall Street Target
$29.79
(+21.2%)
Revenue Growth (YoY)
14.9%
Earnings Growth (YoY)
-15.4%
Profit Margin
-5.0%
Valuation Discount vs History
-1.4% cheaper
PE vs Historical
20.3 vs 21.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.4%
(market-implied from PE analysis)
1-Year Target
$24.23
(-1%)
2-Year Target
$23.89
(-3%)
3-Year Target
$23.55
(-4%)
3-Yr Target (if PE normalizes)
(PE: 20→21)
$24.55
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 12.0%)
$37.31
(+52%)
Base:
(SPY PE: 20.2, Growth: 12.0%)
$34.48
(+40%)
Bear:
(PE: 17.2, Growth: 12.0%)
$29.31
(+19%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 20.2 to 21.1
Stabilization Target:
$25.61
(+4.2%)
PE Expansion Potential:
+4.2%
Share & Embed Analysis
Last updated: June 03, 2026 6:25 PM ET
Data refreshes hourly during market hours. Next update: 7:25 PM
Data refreshes hourly during market hours. Next update: 7:25 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAN showing a specific setup today?
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Lawrence Erik Kurzius
BUY
10000 shares
2025-12-12
Jeffrey N Simmons
BUY
22000 shares
2025-12-11
Rajeev A Modi
BUY
4500 shares
2025-12-11
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$192 | 66 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 60 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$104 | 56 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 58 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$23 | 55 HOLD |
Advanced ELAN Option Strategies
Professional options setups generated by AI based on today's ELAN price and gamma walls.
